Overview

Cromoglycate Adjunctive Therapy for Outpatients With Schizophrenia

Status:
Recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
This is a double blind adjunctive randomized controlled trial for schizophrenia using cromoglicate.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Vishwajit Nimgaonkar, MD PhD
Collaborator:
Stanley Medical Research Institute
Treatments:
Cromolyn Sodium